VYGR Voyager Therapeutics PE ratio, current and historical analysis
The current PE ratio for Voyager Therapeutics stock as of Nov 22, 2024 is 8.2. This is calculated based on the current EPS of $0.69 and the stock price of $5.66 per share.
VYGR PE ratio history
The average historical PE ratio of Voyager Therapeutics for the last nine years is 6.87. The current PE ratio of 8.2 is 19% above the historical average. Over the past nine years, VYGR's PE ratio was at its highest in the Jun 2024 quarter at 30.42, when the stock price was $7.91 and the EPS was $0.26. The lowest value was in the Sep 2016 quarter, when it reached 0.79 with a price of $12.01 and an EPS of $15.21.
Voyager Therapeutics PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 2.74 | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | 7.22 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
VYGR average PE ratio chart
Currently, VYGR's PE ratio is below the 3 and 5-year averages.
VYGR PE vs peers
Compared to its peer stock ORMP, VYGR's PE ratio stands lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| VYGR Voyager Therapeutics Inc | 8.2 | $308.91M |
| ORMP Oramed Pharmaceuticals Inc | 21.27 | $94.33M |
| OLMA Olema Pharmaceuticals Inc | N/A | $503.08M |
| OMER Omeros Corp | N/A | $632.23M |
| OMGA Omega Therapeutics Inc | N/A | $43.52M |
| ONCT Oncternal Therapeutics Inc | N/A | $3.37M |
| ONVO Organovo Holdings Inc | N/A | $6.15M |
| ORIC Oric Pharmaceuticals Inc | N/A | $676.74M |
Frequently asked questions
What is Voyager Therapeutics's PE ratio?
The price to earnings ratio for VYGR stock as of Nov 22, 2024, stands at 8.2.
What is the 3-year average PE ratio for Voyager Therapeutics (VYGR)?
The average PE ratio for VYGR stock over the past 3 years is 9.25.
What is the 5-year average PE ratio for Voyager Therapeutics (VYGR)?
The average PE ratio for VYGR stock over the past 5 years is 8.56.
What is the highest PE ratio for VYGR?
The highest quarterly PE ratio in the last nine years has been 30.42 and it was in the Jun 2024 quarter.
How does the current PE ratio for VYGR compare to its historical average?
The current price to earnings ratio of VYGR is 19% higher than the 9-year historical average.
Why is Voyager Therapeutics's PE ratio so low?
A company with a lower PE ratio may indicate that the market has lower growth expectations for the company's future earnings.
How is VYGR's PE ratio calculated (Voyager Therapeutics PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 22, 2024), Voyager Therapeutics's stock price is $5.66. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.69. Therefore, Voyager Therapeutics's P/E ratio for today is 8.2. PE RATIO(8.2) = STOCK PRICE($5.66) / TTM EPS($0.69)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.